CD8A and neoplasm: 225Ac-NM600 elicited notable cellular immunomodulatory effects, particularly through the depletion of Tregs and myeloid-derived suppressor cells (MDSCs), which resulted in an increased CD8+/Treg-MDSC ratio in TRAMP-C1 tumor-bearing mice.